Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | MER proto-oncogene, tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | AXL receptor tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | TYRO3 protein tyrosine kinase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | IPR008957,Fibronectin, type III-like fold,domain-containing | Get druggable targets OG5_132328 | All targets in OG5_132328 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0017 | 0.1369 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.1369 | 0.2302 |
Echinococcus granulosus | roundabout 2 | 0.0021 | 0.3491 | 0.3491 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0021 | 0.3491 | 0.5988 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.0021 | 0.3491 | 0.3491 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0019 | 0.2361 | 0.4024 |
Schistosoma mansoni | nephrin | 0.0028 | 0.7878 | 0.9933 |
Loa Loa (eye worm) | projectin | 0.0017 | 0.1369 | 0.2302 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0019 | 0.2361 | 0.2237 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.3491 | 0.4789 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.1413 | 0.01 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.58 | 1 |
Schistosoma mansoni | receptor tyrosine phosphatase type r2a | 0.0021 | 0.3491 | 0.3238 |
Echinococcus multilocularis | transfer RNA-Phe | 0.0017 | 0.1369 | 0.1369 |
Echinococcus granulosus | titin | 0.0017 | 0.1369 | 0.1369 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0018 | 0.1608 | 0.1608 |
Schistosoma mansoni | cell adhesion molecule | 0.0021 | 0.3491 | 0.3238 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.1369 | 0.2302 |
Echinococcus granulosus | titin | 0.0017 | 0.1369 | 0.1369 |
Schistosoma mansoni | cell adhesion molecule | 0.0028 | 0.7922 | 1 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0025 | 0.58 | 1 |
Echinococcus granulosus | contactin | 0.0021 | 0.3491 | 0.3491 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.2122 | 0.361 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0025 | 0.58 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.58 | 1 |
Echinococcus multilocularis | roundabout 2 | 0.0021 | 0.3491 | 0.3491 |
Echinococcus granulosus | Down syndrome cell adhesion molecule | 0.0017 | 0.1413 | 0.1413 |
Schistosoma mansoni | cell adhesion molecule | 0.0021 | 0.3491 | 0.3238 |
Echinococcus multilocularis | roundabout 2 | 0.0032 | 1 | 1 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase F | 0.0021 | 0.3491 | 0.3491 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.1413 | 0.2379 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0021 | 0.3491 | 0.5988 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.2122 | 0.361 |
Echinococcus multilocularis | roundabout 2 | 0.0021 | 0.3491 | 0.3491 |
Schistosoma mansoni | ephrin receptor | 0.0018 | 0.1608 | 0.0364 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.3491 | 0.4789 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0018 | 0.1608 | 0.1608 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0021 | 0.3491 | 0.3491 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0044 | 0.0044 |
Onchocerca volvulus | 0.0017 | 0.1369 | 0.5 | |
Brugia malayi | hypothetical protein | 0.0025 | 0.58 | 1 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0017 | 0.1369 | 0.2302 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.3491 | 0.4789 |
Echinococcus granulosus | neuroglian | 0.0021 | 0.3491 | 0.3491 |
Echinococcus granulosus | roundabout 2 | 0.0021 | 0.3491 | 0.3491 |
Echinococcus granulosus | nephrin | 0.0017 | 0.1369 | 0.1369 |
Onchocerca volvulus | 0.0017 | 0.1369 | 0.5 | |
Echinococcus multilocularis | Down syndrome cell adhesion molecule | 0.0017 | 0.1413 | 0.1413 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.3491 | 0.5988 |
Schistosoma mansoni | neuroglian | 0.0021 | 0.3491 | 0.3238 |
Echinococcus multilocularis | titin | 0.0017 | 0.1369 | 0.1369 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.1369 | 0.2302 |
Loa Loa (eye worm) | CAMK protein kinase | 0.0017 | 0.1369 | 0.2302 |
Schistosoma mansoni | nephrin | 0.0021 | 0.3491 | 0.3238 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.1369 | 0.2302 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.0021 | 0.3491 | 0.3491 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0017 | 0.1369 | 0.1369 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.58 | 1 |
Echinococcus multilocularis | neuroglian | 0.0021 | 0.3491 | 0.3491 |
Echinococcus multilocularis | contactin neuroglian septate junction protein | 0.0021 | 0.3491 | 0.3491 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.1369 | 0.2302 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.067 uM | Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay | ChEMBL. | 24219778 |
IC50 (binding) | = 3 uM | Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay | ChEMBL. | 24219778 |
IC50 (binding) | = 6.7 uM | Inhibition of Tyro-3 kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay | ChEMBL. | 24219778 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.